LAWRENCEVILLE, N.J., May 3 Aton Pharma, Inc. announced today that results from a large (n = 520) multi-center patient registry study of its Lacrisert® ophthalmic insert showed that the insert ...
A prescription lubricant insert designed to combat dry eye syndrome can serve as an effective alternative or adjunct treatment, especially for patients using multiple daily doses of artificial tears, ...
Lacrisert now available from Aton Aton Pharma has launched Lacrisert (hydroxypropyl cellulose ophthalmic insert) for the treatment of moderate-to-severe dry eye syndromes. Aton Pharma has launched ...
LAWRENCEVILLE, N.J., Jan. 24 Aton Pharma, Inc., a globalspecialty pharmaceutical company, announced today that it has launched anexpanded, comprehensive distribution program that incorporates sampling ...
A hydroxypropyl cellulose ophthalmic insert minimized dry eye symptoms and improved quality of life in patients with moderate to severe dry eye syndrome in a recent study. The insert also showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results